Search Results - "Subash, Chezhian"

Study of Twenty One Cases of Red Cell Exchange in a Tertiary Care Hospital in Southern India by Daniel, M Joshua, Muddegowda, Prakash H, Chezhiansubash, Lingegowda, Jyothi B, Gopal, Niranjan, Prasad, Krishna

“…Red Cell Exchange (RCE) is removal of a patient's red blood cells while replacing with donor red blood cells either manually or using automated systems. RCE is…”
Get full text

Management of Indian Haematology Patients during COVID19 Crisis by Subash, Chezhian, Kumar, Kishore

“…Introduction :- In current COVID19 situation, we have tried to formulate a practical approach for managing haematology patients, which we have been following…”
Get full text

Comparison of 140mg/m2 vs 200mg/m2 Dose of Melphalan in Myeloma Autograft - a Single Centre Experience from Chennai, India by Kumar, Kishore, Subash, Chezhian

“…Introduction: - Melphalan at a dose of 200mg/m2 is considered the standard autograft dose in patients with multiple myeloma without significant co-morbidity…”
Get full text

On Demand Plerixafor As a Rescue Strategy in Healthy Donors to Achieve Adequate Stem Cells - a Pilot Study from South India by Kumar, Kishore, Subash, Chezhian

“…Aims & Objectives: The aim of the study is to check the safety and feasibility of using Plerixafor in healthy donors who have failed to mobilise > 2 x 10 6/kg…”
Get full text

Hodgkin Lymphoma - Mitigating Toxicity While Preserving Cure - Eight Year Data from MIOT International, Chennai, India by Kumar, Kishore, Subash, Chezhian, Prabhu, Durai, R, Manikandan, Dr, Senthooran

“…Background One of the most treatable cancers, Hodgkin's lymphoma (HL), has a 5-year survival rate of approximately 85%.We still see relapse and refractoriness…”
Get full text

Low Dose Ruxolitinib in Indian Haplo-Identical Transplant Patients with Steroid Refractory Acute Graft Versus Host Disease by Kumar, Kishore, Prabhu, Durai, Kandan, Mani, Thooran, Sen, Subash, Chezhian

Get full text

A Study to Identify Correlation of Hematopoietic Progenitor Cell(XN-HPC) By Sysmex Cell Counters with Final Yield of CD34 + Stem Cells by Kumar, Kishore, Subash, Chezhian s

“…Successful bone marrow transplantation depends on the collection and infusion of enough numbers of peripheral blood stem cells. Several predictors of stem cell…”
Get full text

Pattern of Bacterial Infections in Indian Bone Marrow Transplant Patients - Experience from Chennai India by Kumar, Kishore, Subash, Chezhian, Prabhu, Durai, Pulikkal, Dilshada, Basker, Dharani

“…Introduction: Bone marrow transplant, both Autograft and Allograft produces profound immune-suppression and breach of mucosal surfaces leading to many…”
Get full text

Psychiatric Illness in Indian Bone Marrow Transplant Patients by Prabha, Lakshmi, Kumar, Kishore, Subash, Chezhian, Nambi, Siva

“…Introduction: Bone marrow transplantation is the main stay treatment for various disorders. Psychosocial morbidity associated with Bone Marrow Transplant are…”
Get full text

How We Did Bone Marrow Transplants amidst the COVID19 Pandemic by Kumar, Kishore, Prabhu, Durai, Devi, Dharani, Pulikkal, Dilshada, Daniel, Joshua, Subash, Chezhian

“…Introduction COVID19 is the most heard name for the last six months, and the situation seems to worsen now. This pandemic has created significant stress on the…”
Get full text

Experience of Low Dose (25mg/Kg) of Cyclophosphamide (Chennai-Chezhian-Kishore PTCy Protocol) As Post Transplant Cyclophosphamide (PTCy) Dose in Haploidentical Bone Marrow Transplant by Kumar, Kishore, Subash, Chezhian, Prabhu, Durai, Subramanian, Bhagavathy, Maria Doss MBBS, Simon Raj, MBBS, Dharani, Pulikakkal, Dilshada

“…Introduction:- Haploidentical Bone marrow transplantation has become one of the most commonly employed alternative donor techniques, with many centers applying…”
Get full text

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial by Barrington, Sally F, Belada, David, Meignan, Michel, Ptáčník, Václav, Fingerle-Rowson, Günter R, Hiddemann, Wolfgang, Marcus, Robert E, Grigg, Andrew, Quach, Hang, Marlton, Paula, Offner, Fritz, Van eygen, Koen, Roitman, Daryl, Trneny, Marek, Le Du, Katell, Solal-Celigny, Philippe, Cartron, Guillaume, Foussard, Charles, Schmidt, Peter, Sökler, Martin, Schimmelpfennig, Christoph, Tonndorf, Solveig, Hänel, Mathias, Hess, Georg, Schalk, Enrico, Pfreundschuh, Michael, Herold, Michael, Forstpointner, Roswitha, Vehling-Kaiser, Ursula, Majolino, Ignazio, Balzarotti, Monica, Soler Campos, Alfonso, Marquez Navarro, Jose Antonio, Grande Garcia, Carlos, Nilsson-Ehle, Herman, Radford, John, Kruger, Anton, Culligan, Dominic, Dyer, Martin, Pettengell, Ruth, Al-Ismail, Saad, Al-Refaie, Faris, Blesing, Norbert, Macnamara, Christopher, O'callaghan, Ann, Haynes, Andrew, Bowles, Kristian, Gallop-Evans, Eve, Bailey, James, De Oliveira, Moacyr, Tezcan, Haluk, Kim, Kevin, Hatake, Kiyohiko, Ogura, Michinori, Uchida, Toshiki, Kinoshita, Tomohiro, Kirsch, Andreas, Koenigsmann, Michael, Dürig, Jan, Kneba, Michael, Bergmann, Lothar, Marks, Reinhard, Wulf, Gerald, Schmits, Rudolf, Lengfelder, Eva, Scott, Fiona, Taniwaki, Masafumi, Yoshida, Isao, Uike, Naokuni, Kamitsuji, Yuri, Iida, Shinsuke, Ohmine, Ken, Nosaka, Kisato, Ide, Kazuhiko, Ishikawa, Takayuki, Li, Wei, Yu, Li, Shi, Yuan Kai, Hong, Xiaonan, Feng, Jifeng, Zhan, Rong, Lin, Tongyu, Costello, Regis, Tournilhac, Olivier, Kirchen, Heinz, Hebart, Holger, Gurion, Ronit, Shpilberg, Ofer, Leoni, Pietro, Samoylova, Olga, Usui, Noriko, Izutsu, Koji, Ichinohe, Tatsuo, Kubo, Kohmei, Ishida, Fumihiro, Dakhil, Shaker, Maruyama, Dai, Kobayashi, Tsutomu, Wada, Katsuya, Minami, Yosuke

“…Initial results from the ongoing GALLIUM trial have shown that patients with follicular lymphoma have a longer progression-free survival after first-line…”
Get full text

Efficacy and Safety of Ibrutinib in Indian Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Cases from a Named Patient Program by Agarwal, Mohan B, Bhurani, Dinesh, Shah, Chirag, Sood, Nitin, Singhal, Manish, Kamat, Anil, Chezhian, Subash, Mishra, Suryaprakash, Nagrale, Dinesh

“…Abstract Context: This named patient program evaluated the safety and efficacy of ibrutinib, a selective inhibitor of Bruton's tyrosine kinase in Indian…”
Get full text

IgM myeloma: a rare entity characterized by a CD20−CD56−CD117− immunophenotype and the t(11;14) by Feyler, Sylvia, O’Connor, Sheila J. M., Rawstron, Andy C., Subash, Chezhian, Ross, Fiona M., Pratt, Guy, Drayson, Mark T., Ashcroft, John, Cook, Gordon, Owen, Roger G.

“…Summary IgM myeloma is a very rare and poorly defined entity. In a detailed assessment of 10 cases, it was demonstrated that 70% had an aberrant phenotype…”
Get full text

Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference by Yanamandra, Uday, Khattry, Navin, Kumar, Shaji, Raje, Noopur, Jain, Arihant, Jagannath, Sundar, Menon, Hari, Kumar, Lalit, Varma, Neelam, Varma, Subhash, Saikia, Tapan, Malhotra, Pankaj

“…The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent…”
Get full text